The company was founded in May 1999 and listed on the Shenzhen Stock Exchange in June 2015. Saisheng Pharmaceutical is rooted in the pharmaceutical industry, with innovation and R&D as the foundation, market and sales orientation, safety and effectiveness as the guarantee, service as the purpose, and is committed to the industrialization of life science technology. Through independent innovation, integration of upstream and downstream industry chains, and capital market operations, it has accelerated its layout to cover fields related to the life science and health industry, effectively achieving strategic expansion plans and capital appreciation of the industry. The company's main business is R&D, production and sales of injectable injections. The company's main products are biological and biochemical drugs, covering the three major fields of use for cardiovascular diseases, immune diseases (anti-tumor), and neurological diseases. Company honors: Zhongguancun High-tech Enterprise, Beijing Patent Demonstration Unit, Capital Civilized Unit, Beijing Honest Creation Enterprise, etc.